Heres what they found: In the diabetes group: 17 out of 194 patients taking semaglutide developed NAION ( 8.9% ) 6 out of 516 patients taking non-semaglutide drugs developed NAION ( 1.8% ) In the overweight or obese group: 20 out of 361 patients taking semaglutide developed NAION ( 6.7% ) 3 out of 618 patients taking non-semaglutide drugs developed NAION ( 0.8% ) We can see from these numbers that more people who were taking semaglutide developed this eye condition, compared with those who were taking different medications
Semaglutide Interactions May delay gastric emptying, affecting absorption of oral medications (e.g., levothyroxine) Concomitant use with insulin or sulfonylureas increases the risk of hypoglycemia
Ji C, Zhang Z, Li Z, She X, Wang X, Li B et al (2022) Mitochondria-Associated Endoplasmic reticulum membranes: inextricably linked with autophagy process
Other risk factors for lymphedema include having an infection, healing slowly after surgery, having lymph nodes removed, past surgeries or radiation, having advanced cancer, and being overweight or having obesity
One, tirzepatide sold under the brand name Mounjaro carries a warning specifically about birth control pills, stating that the medication could make them less effective
10.1056/NEJMoa2107519 [DOI] [PubMed] [Google Scholar] 30
